Ozone inhalation promotes CX3CR1-dependent maturation of resident lung macrophages that limit oxidative stress and inflammation

Journal of Immunology

Volumn 187, Issue 9, 2011, Pages 4800-4808

  Tighe, Robert M ^a   Li, Zhuowei ^a   Potts, Erin N ^a   Frush, Sarah ^a   Liu, Ningshan ^a   Gunn, Michael D ^a   Foster, W Michael ^a   Noble, Paul W ^a   Hollingsworth, John W ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTANE; CHEMOKINE RECEPTOR CX3CR1; CXCL2 CHEMOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL POPULATION; CONTROLLED STUDY; CX3CR1 GENE; GENE; GENE OVEREXPRESSION; LUNG ALVEOLUS MACROPHAGE; MARCO GENE; MONOCYTE; MOUSE; NADPH GENE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

ADMINISTRATION, INTRANASAL; ANIMALS; CELL DIFFERENTIATION; FEMALE; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; OZONE; RECEPTORS, CHEMOKINE; RECEPTORS, IMMUNOLOGIC;

EID: 80555126063     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101312     Document Type: Article

References (56)

1. Ciencewicki, J., S. Trivedi, and S. R. Kleeberger. 2008. Oxidants and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 122: 456-468, quiz 469-470.
2. Foster, W. M., and P. T. Stetkiewicz. 1996. Regional clearance of solute from the respiratory epithelia: 18-20 h postexposure to ozone. J. Appl. Physiol. 81: 1143-1149. (Pubitemid 26309120)
3. Kehrl, H. R., L. M. Vincent, R. J. Kowalsky, D. H. Horstman, J. J. O'Neil, W. H. McCartney, and P. A. Bromberg. 1987. Ozone exposure increases respiratory epithelial permeability in humans. Am. Rev. Respir. Dis. 135: 1124-1128. (Pubitemid 18021500)
4. Pulfer, M. K., and R. C. Murphy. 2004. Formation of biologically active oxysterols during ozonolysis of cholesterol present in lung surfactant. J. Biol. Chem. 279: 26331-26338. (Pubitemid 38798783)
5. Garantziotis, S., Z. Li, E. N. Potts, K. Kimata, L. Zhuo, D. L. Morgan, R. C. Savani, P. W. Noble, W. M. Foster, D. A. Schwartz, and J. W. Hollingsworth. 2009. Hyaluronan mediates ozone-induced airway hyper-responsiveness in mice. J. Biol. Chem. 284: 11309-11317.
6. Al-Hegelan, M., R. M. Tighe, C. Castillo, and J. W. Hollingsworth. 2011. Ambient ozone and pulmonary innate immunity. Immunol. Res. 49: 173-191.
7. Pendino, K. J., T. M. Meidhof, D. E. Heck, J. D. Laskin, and D. L. Laskin. 1995. Inhibition of macrophages with gadolinium chloride abrogates ozone-induced pulmonary injury and inflammatory mediator production. Am. J. Respir. Cell Mol. Biol. 13: 125-132.
8. Hotchkiss, J. A., J. R. Harkema, D. T. Kirkpatrick, and R. F. Henderson. 1989. Response of rat alveolar macrophages to ozone: quantitative assessment of population size, morphology, and proliferation following acute exposure. Exp. Lung Res. 15: 1-16. (Pubitemid 19059517)
9. Arsalane, K., P. Gosset, D. Vanhee, C. Voisin, Q. Hamid, A. B. Tonnel, and B. Wallaert. 1995. Ozone stimulates synthesis of inflammatory cytokines by alveolar macrophages in vitro. Am. J. Respir. Cell Mol. Biol. 13: 60-68.
10. Dahl, M., A. K. Bauer, M. Arredouani, R. Soininen, K. Tryggvason, S. R. Kleeberger, and L. Kobzik. 2007. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J. Clin. Invest. 117: 757-764. (Pubitemid 46348534)
11. Ishii, Y., K. Hashimoto, A. Nomura, T. Sakamoto, Y. Uchida, M. Ohtsuka, S. Hasegawa, and M. Sagai. 1998. Elimination of neutrophils by apoptosis during the resolution of acute pulmonary inflammation in rats. Lung 176: 89-98. (Pubitemid 28093780)
12. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964. (Pubitemid 41746764)
13. Careau, E., and E. Y. Bissonnette. 2004. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am. J. Respir. Cell Mol. Biol. 31: 22-27. (Pubitemid 38888035)
14. Maus, U., J. Huwe, R. Maus, W. Seeger, and J. Lohmeyer. 2001. Alveolar JE/ MCP-1 and endotoxin synergize to provoke lung cytokine upregulation, sequential neutrophil and monocyte influx, and vascular leakage in mice. Am. J. Respir. Crit. Care Med. 164: 406-411. (Pubitemid 32778207)
15. Taut, K., C. Winter, D. E. Briles, J. C. Paton, J. W. Christman, R. Maus, R. Baumann, T. Welte, and U. A. Maus. 2008. Macrophage turnover kinetics in the lungs of mice infected with Streptococcus pneumoniae. Am. J. Respir. Cell Mol. Biol. 38: 105-113.
16. Lin, K. L., Y. Suzuki, H. Nakano, E. Ramsburg, and M. D. Gunn. 2008. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 180: 2562-2572.
17. Tighe, R. M., J. Liang, N. Liu, Y. Jung, D. Jiang, M. D. Gunn, and P. W. Noble. 2011. Recruited exudative macrophages selectively produce CXCL10 following non-infectious lung injury. Am. J. Respir. Cell Mol. Biol. February 17, 2011.
18. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82. (Pubitemid 36859902)
19. Landsman, L., C . Varol, and S. Jung. 2007. Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178: 2000-2007. (Pubitemid 46233396)
20. Landsman, L., and S. Jung. 2007. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J. Immunol. 179: 3488-3494.
21. Tsou, C. L., W. Peters, Y. Si, S. Slaymaker, A. M. Aslanian, S. P. Weisberg, M. Mack, and I. F. Charo. 2007. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Invest. 117: 902-909. (Pubitemid 46556746)
22. Maus, U., S. Herold, H. Muth, R. Maus, L. Ermert, M. Ermert, N. Weissmann, S. Rosseau, W. Seeger, F. Grimminger, and J. Lohmeyer. 2001. Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14. Am. J. Physiol. Lung Cell. Mol. Physiol. 280: L58-L68.
23. Janssen, W. J., L. Barthel, A. Muldrow, R. E. Oberley-Deegan, M. T. Kearns, C. Jakubzick, and P. M. Henson. 2011. Fas determines differential fates of resident and recruited macrophages during resolution of acute lung injury. Am. J. Respir. Crit. Care Med. March 31, 2011.
24. Wilson, A. A., G. J. Murphy, H. Hamakawa, L. W. Kwok, S. Srinivasan, A. H. Hovav, R. C. Mulligan, S. Amar, B. Suki, and D. N. Kotton. 2010. Amelioration of emphysema in mice through lentiviral transduction of long-lived pulmonary alveolar macrophages. J. Clin. Invest. 120: 379-389.
25. Jennings, J. H., D. J. Linderman, B. Hu, J. Sonstein, and J. L. Curtis. 2005. Monocytes recruited to the lungs of mice during immune inflammation ingest apoptotic cells poorly. Am. J. Respir. Cell Mol. Biol. 32: 108-117. (Pubitemid 40189692)
26. Cardona, A. E., M. E. Sasse, L. Liu, S. M. Cardona, M. Mizutani, C. Savarin, T. Hu, and R. M. Ransohoff. 2008. Scavenging roles of chemokine receptors: chemokine receptor deficiency is associated with increased levels of ligand in circulation and tissues. Blood 112: 256-263.
27. Garantziotis, S., Z. Li, E. N. Potts, J. Y. Lindsey, V. P. Stober, V. V. Polosukhin, T. S. Blackwell, D. A. Schwartz, W. M. Foster, and J. W. Hollingsworth. 2010. TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation. Am. J. Respir. Crit. Care Med. 181: 666-675.
28. Pendino, K. J., R. L. Shuler, J. D. Laskin, and D. L. Laskin. 1994. Enhanced production of interleukin-1, tumor necrosis factor-alpha, and fibronectin by rat lung phagocytes following inhalation of a pulmonary irritant. Am. J. Respir. Cell Mol. Biol. 11: 279-286.
29. Devlin, R. B., K. P. McKinnon, T. Noah, S. Becker, and H. S. Koren. 1994. Ozone-induced release of cytokines and fibronectin by alveolar macrophages and airway epithelial cells. Am. J. Physiol. 266: L612-L619.
30. Becker, S., M. C. Madden, S. L. Newman, R. B. Devlin, and H. S. Koren. 1991. Modulation of human alveolar macrophage properties by ozone exposure in vitro. Toxicol. Appl. Pharmacol. 110: 403-415.
31. Janic, B., T. M. Umstead, D. S. Phelps, and J. Floros. 2005. Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation. Am. J. Physiol. Lung Cell. Mol. Physiol. 288: L317-L325. (Pubitemid 40105370)
32. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
33. Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147: 22-28.
34. Hatta, M., N. Yamamoto, A. Miyazato, N. Ishii, K. Nakamura, K. Inden, T. Aoyagi, H. Kunishima, Y. Hirakata, K. Suzuki, et al. 2010. Early production of tumor necrosis factor-alpha by Gr-1 cells and its role in the host defense to pneumococcal infection in lungs. FEMS Immunol. Med. Microbiol. 58: 182-192.
35. Lyadova, I. V., E. N. Tsiganov, M. A. Kapina, G. S. Shepelkova, V. V. Sosunov, T. V. Radaeva, K. B. Majorov, N. S. Shmitova, H. J. van den Ham, V. V. Ganusov, et al. 2010. In mice, tuberculosis progression is associated with intensive inflammatory response and the accumulation of Gr-1 cells in the lungs. PLoS ONE 5: e10469.
36. Moran, J. L., D. Siegel, and D. Ross. 1999. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H: quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. USA 96: 8150-8155. (Pubitemid 29328423)
37. Radjendirane, V., P. Joseph, Y. H. Lee, S. Kimura, A. J. Klein-Szanto, F. J. Gonzalez, and A. K. Jaiswal. 1998. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J. Biol. Chem. 273: 7382-7389. (Pubitemid 28152759)
38. Zhu, H., Z. Jia, L. Zhang, M. Yamamoto, H. P. Misra, M. A. Trush, and Y. Li. 2008. Antioxidants and phase 2 enzymes in macrophages: regulation by Nrf2 signaling and protection against oxidative and electrophilic stress. Exp. Biol. Med. (Maywood) 233: 463-474. (Pubitemid 351469303)
39. Ross, D., D. Siegel, D. G. Schattenberg, X. M. Sun, and J. L. Moran. 1996. Cell-specific activation and detoxification of benzene metabolites in mouse and human bone marrow: identification of target cells and a potential role for modulation of apoptosis in benzene toxicity. Environ. Health Perspect. 104(Suppl 6): 1177-1182. (Pubitemid 27046145)
40. Srivastava, M., S. Jung, J. Wilhelm, L. Fink, F. Bühling, T. Welte, R. M. Bohle, W. Seeger, J. Lohmeyer, and U. A. Maus. 2005. The inflammatory versus constitutive trafficking of mononuclear phagocytes into the alveolar space of mice is associated with drastic changes in their gene expression profiles. J. Immunol. 175: 1884-1893. (Pubitemid 41023095)
41. Maus, U. A., S. Janzen, G.Wall, M. Srivastava, T. S. Blackwell, J.W. Christman, W. Seeger, T. Welte, and J. Lohmeyer. 2006. Resident alveolar macrophages are replaced by recruited monocytes in response to endotoxin-induced lung inflammation. Am. J. Respir. Cell Mol. Biol. 35: 227-235. (Pubitemid 44175323)
42. Blackwell, T. S., L. H. Lancaster, T. R. Blackwell, A. Venkatakrishnan, and J. W. Christman. 1999. Chemotactic gradients predict neutrophilic alveolitis in endotoxin-treated rats. Am. J. Respir. Crit. Care Med. 159: 1644-1652. (Pubitemid 29227882)
43. Hollingsworth, J. W., II, D. N. Cook, D. M. Brass, J. K. Walker, D. L. Morgan, W. M. Foster, and D. A. Schwartz. 2004. The role of Toll-like receptor 4 in environmental airway injury in mice. Am. J. Respir. Crit. Care Med. 170: 126-132.
44. Borges, V. M., R. W. Vandivier, K. A. McPhillips, J. A. Kench, K. Morimoto, S. D. Groshong, T. R. Richens, B. B. Graham, A. M. Muldrow, L. Van Heule, et al. 2009. TNFalpha inhibits apoptotic cell clearance in the lung, exacerbating acute inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 297: L586-L595.
45. Teder, P., R. W. Vandivier, D. Jiang, J. Liang, L. Cohn, E. Puré, P. M. Henson, and P.W. Noble. 2002. Resolution of lung inflammation by CD44. Science 296: 155-158. (Pubitemid 34280077)
46. Imai, T., K. Hieshima, C. Haskell, M. Baba, M. Nagira, M. Nishimura, M. Kakizaki, S. Takagi, H. Nomiyama, T. J. Schall, and O. Yoshie. 1997. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91: 521-530. (Pubitemid 27508241)
47. Foussat, A., A. Coulomb-L'Hermine, J. Gosling, R. Krzysiek, I. Durand- Gasselin, T. Schall, A. Balian, Y. Richard, P. Galanaud, and D. Emilie. 2000. Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human. Eur. J. Immunol. 30: 87-97. (Pubitemid 30011769)
48. Suzuki, F., T. Nanki, T. Imai, H. Kikuchi, S. Hirohata, H. Kohsaka, and N. Miyasaka. 2005. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice. J. Immunol. 175: 6987-6996. (Pubitemid 41598945)
49. -/- mice reveals a role for fractalkine in atherogenesis. J. Clin. Invest. 111: 333-340.
50. Inoue, A., H. Hasegawa, M. Kohno, M. R. Ito, M. Terada, T. Imai, O. Yoshie, M. Nose, and S. Fujita. 2005. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice. Arthritis Rheum. 52: 1522-1533. (Pubitemid 40663944)
51. Xiong, Z., A. S. Leme, P. Ray, S. D. Shapiro, and J. S. Lee. 2011. CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-α and IL-6 and promote cigarette smoke-induced emphysema. J. Immunol. 186: 3206-3214.
52. Fujimoto, K., T. Imaizumi, H. Yoshida, S. Takanashi, K. Okumura, and K. Satoh. 2001. Interferon-gamma stimulates fractalkine expression in human bronchial epithelial cells and regulates mononuclear cell adherence. Am. J. Respir. Cell Mol. Biol. 25: 233-238. (Pubitemid 32752450)
53. Balabanian, K., A. Foussat, P. Dorfmüller, I. Durand-Gasselin, F. Capel, L. Bouchet-Delbos, A. Portier, A. Marfaing-Koka, R. Krzysiek, A. C. Rimaniol, et al. 2002. CX(3)C chemokine fractalkine in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 165: 1419-1425. (Pubitemid 34522947)
54. McComb, J. G., M. Ranganathan, X. H. Liu, J. M. Pilewski, P. Ray, S. C. Watkins, A. M. Choi, and J. S. Lee. 2008. CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema. Am. J. Pathol. 173: 949-961.
55. Rimaniol, A. C., S. J. Till, G. Garcia, F. Capel, V. Godot, K. Balabanian, I. Durand-Gasselin, E. M. Varga, G. Simonneau, D. Emilie, et al. 2003. The CX3C chemokine fractalkine in allergic asthma and rhinitis. J. Allergy Clin. Immunol. 112: 1139-1146. (Pubitemid 37550007)
56. Mionnet, C., V. Buatois, A. Kanda, V. Milcent, S. Fleury, D. Lair, M. Langelot, Y. Lacoeuille, E. Hessel, R. Coffman, et al. 2010. CX3CR1 is required for airway inflammation by promoting T helper cell survival and maintenance in inflamed lung. Nat. Med. 16: 1305-1312.